Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 6NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Mycoses 1Hematologic Neoplasms 1

Interventions

Specimen Handling 2Methods 2Educational Status 2Early Intervention, Educational 2trihexyltetradecylphosphonium chloride 1letermovir 1gamma-Globulins 1Voriconazole 1Vincristine 1Vaccination 1Sirolimus 1Prednisone 1Pharmacogenomic Testing 1Patient Navigation 1Organizational Objectives 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Lenalidomide 1Interviews as Topic 1Infliximab 1Immunoglobulins, Intravenous 1Immunoglobulins 1Health Promotion 1Fluconazole 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Caspofungin 1Carvedilol 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hematologic Neoplasms × Voriconazole × Clear all
NCT01503515 2024-10-16

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Children's Oncology Group

Phase 3 Completed
292 enrolled 12 charts
Other hematologic neoplasm

Mycoses, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡